Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 30,749,000 | 28,817,000 | 29,253,041 | 29,489,295 | 28,491,241 |
| Cost of Goods | 7,880,000 | 7,337,000 | 7,582,979 | 7,586,750 | 7,559,952 |
| Gross Profit | 22,869,000 | 21,480,000 | 21,670,063 | 21,902,545 | 20,931,289 |
| Operating Expenses | 15,051,000 | 15,579,000 | 15,612,459 | 15,898,609 | 15,211,089 |
| Operating Income | 7,818,000 | 5,901,000 | 6,057,604 | 6,003,936 | 5,720,200 |
| Interest Expense | 324,000 | 335,000 | N/A | N/A | N/A |
| Other Income | -1,428,000 | -1,404,000 | -276,406 | -1,256,250 | -3,079,199 |
| Pre-tax Income | 6,066,000 | 4,162,000 | 5,781,198 | 4,747,686 | 2,641,002 |
| Income Tax | 1,364,000 | 682,000 | 687,928 | 800,121 | 477,035 |
| Net Income Continuous | 5,516,000 | 4,733,000 | 5,271,597 | 4,005,907 | 2,255,996 |
| Net Income Discontinuous | 175,000 | N/A | N/A | N/A | N/A |
| Minority Interests | -426,000 | -441,000 | -419,752 | -393,241 | -334,347 |
| Net Income | $5,265,000 | $4,292,000 | $5,271,597 | $4,005,907 | $2,255,996 |
| EPS Basic Total Ops | 4.03 | 2.94 | 3.92 | 2.97 | 1.68 |
| EPS Basic Continuous Ops | 4.03 | 2.94 | 3.92 | 2.97 | 1.68 |
| EPS Diluted Total Ops | 4.03 | 2.94 | 3.90 | 2.95 | 1.67 |
| EPS Diluted Continuous Ops | 4.03 | 2.94 | 3.90 | 2.95 | 1.67 |
| EBITDA(a) | $11,401,000 | $10,482,000 | $10,729,064 | $12,116,978 | $11,666,676 |